Busca avançada
Ano de início
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

In vivo vascular rarefaction and hypertension induced by dexamethasone are related to phosphatase PTP1B activation not endothelial metabolic changes

Texto completo
Herrera, Naiara Araujo [1, 2] ; Duchatsch, Francine [1, 2] ; Kahlke, Allison [3] ; Amaral, Sandra Lia [1, 2] ; Vasquez-Vivar, Jeannette [3]
Número total de Autores: 5
Afiliação do(s) autor(es):
[1] PIPGCE UFSCar UNESP, Joint Grad Program Physiol Sci, Rodovia Washington Luiz, Sao Carlos, SP - Brazil
[2] Sao Paulo State Univ, Sch Sci, Dept Phys Educ, Av Eng Luiz Edmundo Carrijo Coube, Sao Paulo, SP - Brazil
[3] Med Coll Wisconsin, Dept Biophys, Redox Biol Program, Milwaukee, WI 53226 - USA
Número total de Afiliações: 3
Tipo de documento: Artigo Científico
Fonte: Free Radical Biology and Medicine; v. 152, p. 689-696, MAY 20 2020.
Citações Web of Science: 0

Glucocorticoids have important anti-inflammatory and immunomodulatory activities. Dexamethasone (Dex), a synthetic glucocorticoid, induces insulin resistance, hyperglycemia, and hypertension. The hypertensive me- chanisms of Dex are not well understood. Previously, we showed that exercise training prior to Dex treatment significantly decreases blood vessel loss and hypertension in rats. In this study, we examined whether the sa- lutary effects of exercise are associated with an enhanced metabolic profile. Analysis of the NAD and ATP content in the tibialis anterior muscle of trained and non -trained animals indicated that exercise increases both NAD and ATP; however, Dex treatment had no effect on any of the experimental groups. Likewise, Dex did not change NAD and ATP in cultured endothelial cells following 24 h and 48 h of incubation with high con- centrations. Reduced VEGF-stimulated NO production, however, was verified in endothelial cultured cells. Reduced NO was not associated with changes in survival or the BH4 to BH2 ratio. Moreover, Dex had no effect on bradykinin- or shear -stress -stimulated NO production, indicating that VEGF-stimulated eNOS phosphoryla- tion is a target of Dex's effects. The PTP1B inhibitor increased NO in Dex-treated cells in a dose -dependent fashion, an effect that was replicated by the glucocorticoid receptor inhibitor, RU486. In combination, these results indicate that Dex-induced endothelial dysfunction is mediated by glucocorticoid receptor and PTP1B activation. Moreover, since exercise reduces the expression of PTP1B and normalized insulin resistance in aging rats, our findings indicate that exercise training by reducing PTP1B activity counteracts Dex-induced hy- pertension in vivo . (AU)

Processo FAPESP: 18/06998-7 - Treinamento físico previne rarefação induzida por dexametasona: papel da mitocôndria
Beneficiário:Naiara Araújo Herrera
Linha de fomento: Bolsas no Exterior - Estágio de Pesquisa - Doutorado
Beneficiário:Naiara Araújo Herrera
Linha de fomento: Bolsas no Brasil - Doutorado
Processo FAPESP: 17/00509-1 - Papel do treinamento físico no balanço autonômico, rigidez arterial e rarefação em ratos espontaneamente hipertensos tratados com dexametasona: contribuição dos microRNAs
Beneficiário:Sandra Lia do Amaral Cardoso
Linha de fomento: Auxílio à Pesquisa - Regular
Processo FAPESP: 17/14405-3 - Influência do treinamento físico aeróbio no remodelamento cardíaco de ratos espontaneamente hipertensos tratados com dexametasona
Beneficiário:Francine Duchatsch Ribeiro de Souza
Linha de fomento: Bolsas no Brasil - Mestrado